|
A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China CNBCLung Cancer Patients on Drug From China's Akeso Lived Longer Bloomberg.comASCO: Akeso's ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% Fierce PharmaAkeso and Summit's ivonescimab extends survival in squamous cell lung cancer statnews.com
|
|
After new drug's ‘unprecedented' results for pancreatic cancer, doctors look at other uses NBC News‘Landmark' pancreatic cancer drug keeps patients alive for twice as long The Washington PostDaily pill can double survival time for world's deadliest cancer, trial shows The GuardianRevolution Medicines starts shipping experimental pancreatic cancer drug statnews.com
|
|
